Showing results (191-200 of 218) with videos related to
Sort By:
Pageof 22
Medical Teacher|March 2, 2018
The development of a pragmatic, clinically driven ultrasound curriculum in a UK medical schoolRichard J Wakefield, Asoka Weerasinghe, Patrick Tung, et al.Respiratory Care|September 23, 2020
A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human SubjectsMichael D Davis, Tatiana M Clemente, Olivia K Giddings, et al.Journal for Immunotherapy of Cancer|December 18, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse eventsMarcela V Maus, Sara Alexander, Michael R Bishop, et al.Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.Trials|November 15, 2023
The SWiFT trial (Study of Whole Blood in Frontline Trauma)-the clinical and cost effectiveness of pre-hospital whole blood versus standard care in patients with life-threatening traumatic haemorrhage: study protocol for a multi-centre randomised controlled trialJason E Smith, Ed B G Barnard, Charlie Brown-O'Sullivan, et al.Frontiers in Social Psychology|November 7, 2025
Quantifying generalized trust in individuals and counties using languageSalvatore Giorgi, Jason Jeffrey Jones, Anneke Buffone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaRegina M Myers, Yimei Li, Allison Barz Leahy, et al.The Journal of Experimental Medicine|June 9, 2021
VISTA is an activating receptor in human monocytesBryan M Rogers, Laura Smith, Zoltan Dezso, et al.Cancers|July 13, 2024
Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated ReviewLucillia Bezu, Dilara Akçal Öksüz, Max Bell, et al.Pilot and Feasibility Studies|June 11, 2022
Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trialGogem Topcu, Laura Smith, Jacqueline R Mhizha-Murira, et al.Pageof 22